CD274 and thymic carcinoma: Furthermore, Shukuya et al. evaluated the efficacy of chemotherapy combined with immune checkpoint inhibitors in patients with thymic carcinoma and reported that higher PD-L1 expression in tumor-infiltrating immune cells was associated with an improved treatment response [50].